BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V} Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BIOTECH & TECHNOLOGY INVESTING *UNDERVALUED*{T/A F/A & V}

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: CPAMarty who wrote (95)	3/10/1999 8:54:00 AM
From: BRAVEHEART	Read Replies (1) of 423

Hi Marty, IMCL is clearly in a solid uptrend. Accumulation certainly. It tops out on each rise...The key is the tops & bottoms are trending up... I remember when Phizer came out with Viagra...ICOS rode the coat tails with it's product. IMCL announced it's potential is greater than GNE's... "Herceptin targets the human epidermal growth factor-2 (HER-2) gene, while C-225 targets HER-1 or EGF, which Waksal says is involved in a wide range of cancers." ''The market for our product is much larger,'' he said. ''Fully one-third of all human solid tumors express the EGF receptor.'' biz.yahoo.com The two announcements in conjunction with one another should do something for the stock. biz.yahoo.com ICOS took off last spring ( when I first targeted it ) on it's similarly structured story. Of course Pfizer received much more media attention of which ICOS benefited. I would still favor a favorable speculative trend. quote.yahoo.com BEST WISHES JEFFREY

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next